•
AL
ALEC
Alector, Inc. Common Stock
yahooBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
209.57M
Volume
617.64K
52W High
$3.40
52W Low
$0.87
Open
$0.00
Prev Close
$1.83
Day Range
0.00 - 0.00
About Alector, Inc. Common Stock
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Latest News
ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm
GlobeNewswire Inc.•Nov 26
Alector Announces Results from its Phase 3 Clinical Trial of Potential FTD-GRN Therapeutic
GlobeNewswire Inc.•Oct 21
Alector to Participate in Upcoming Healthcare Conferences
GlobeNewswire Inc.•Feb 25
Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025
GlobeNewswire Inc.•Jan 13
Alector to Participate in Upcoming Healthcare Conferences
GlobeNewswire Inc.•Aug 29
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
GlobeNewswire Inc.•Jul 28
Prothena (PRTA) Moves 9.3% Higher: Will This Strength Last?
Zacks Investment Research•Jun 24
Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform
GlobeNewswire Inc.•Jun 10